US opioid crisis: Pharmaceutical giants reach deal to avoid lawsuit
By France24
03 November 2019 |
12:50 pm
US opioid crisis: Pharmaceutical giants reach deal to avoid lawsuit
In this article
Related
9 Aug 2017
President Trump scheduled a major briefing on the epidemic of opiod drug use and said his administration will fight it and 'will win'.
7 Nov 2017
France 24 journalists meet eyewitnesses (Observers) to discuss memorable events they have experienced.
24 Apr 2018
Today’s Focus report takes us to Cameroon where we look at a growing addiction to opioids. Readily available on the black market, one of the most abused substances, Tramadol, is now making its way into schoolyards.
13 May 2018
President Donald Trump will propose a sweeping effort to bring down U.S. drug prices Friday, according to senior administration officials, in a plan to make good on a campaign promise.
24 Jun 2018
Pharmaceutical Society of Nigeria destroys 452m worth of expired drugs in Abuja.
6 Jan 2019
Bristol-Myers Squibb Co.’s $74 billion acquisition of drugmaker Celgene Corp. is the biggest deal ever announced this early in a calendar year, according to data compiled by Bloomberg going back to 1990.
14 Mar 2019
The Pharmaceutical Society of Nigeria says the scarcity of foreign exchange in Nigeria over the past few years led to an increase in the cost of imported drugs by almost 200 per cent.
31 Mar 2019
Opioid crisis: Purdue Pharma pays $270 million in historic settlement.
21 Jul 2019
Federal operatives of the Nigerian Customs, Zone A, Lagos have once again intercepted two trucks of pharmaceutical products emanating from India.
27 Aug 2019
Oklahoma's Attorney General accused Johnson & Johnson of a "multi-billion-dollar brainwashing campaign" to get doctors to overprescribe opioids, downplaying the addiction risks. J&J shares surged after the ruling.
11 Sep 2019
US population decimated by opioid overdoses
21 Sep 2019
Purdue Pharma LP opened its first day in bankruptcy court by pledging to continue investigating whether its owners, the Sackler family, who are accused of spurring America’s opioid epidemic, wrongly took cash out of the pharmaceutical maker. Bloomberg's Tom Metcalf and Lisa Abramowicz speak on "Bloomberg's Money Undercover" about the Sacklers.
Latest
22 mins ago
Ivorian cashew processors face an uphill battle. Its bid to expand into processing faces competition from Asia. Also Mali's sanctioned but Senegal loses out. The economic interdependence between the nighbours has left Senegalese traders struggling to cope with the knock on effects of penalties imposed on Bamako. And Amidst Months of sometimes deadly protests against an army take over, young Sudanese have been finding respite from the in Khartoum's vibrant cultural scene.
30 mins ago
During Pride Month, the LGBTQ community marches to defend its rights around the world. Our reporters went to meet some members of its older generation in France and Spain. Older gay, lesbian and trangender people often feel invisible within their wider communities and the majority of them suffer from loneliness after family rifts and years of discrimination. But thanks to the work of younger activists and organisations, LGBTQ seniors are gradually emerging from the margins.
30 mins ago
German pharmaceutical company BioNTech has begun construction of an COVID-19 vaccine plant in Rwanda. When completed, it will be the first mRNA vaccine plant in Africa.
1 hour ago
Germany is looking to lower gas demand to ward off long-term shortages as Russia throttles the gas flow. Gas prices for consumers could rise even more as a consequence.
1 hour ago
A traditional mask was recently given by Belgium to DR Congo as part of efforts to advance the return of cultural artefacts taken during the colonial era. False claims have circulated online stating that the returned mask was not the original but a copy. We take a closer look in this edition of Truth or Fake.
1 hour ago
Germany's financial capital, Frankfurt, climbed 32 places to seventh position, while Hamburg and Düsseldorf came in at 16 and 22, according to an annual index in British weekly The Economist.